Achieving Immune Tolerance through Hematopoietic Mixed Chimerism in Deceased Donation

Date: September 20, 2018

Time: 02:00PM - 03:00PM

You must be registered to participate!

After participating in this webinar, the learner will be able to:

  1. Explain the advantages of tolerance vs. immune suppression.
  2. Evaluate the overall status of clinical transplant tolerance and the protocols used in trials.
  3. Identify current limitations to immune tolerance protocols.
  4. Identify potential solutions through the use of organ and cell preservation technologies.
  5. Evaluate the protocols in trials and the overall status of clinical transplant tolerance.